Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis.
暂无分享,去创建一个
Jurgen J Fütterer | Maroeska M Rovers | Maarten de Rooij | J. Fütterer | M. Rovers | J. Barentsz | M. de Rooij | Jelle O Barentsz | Esther H J Hamoen | E. Hamoen | Maarten de Rooij
[1] W. Shabana,et al. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra‐prostatic extension (EPE) in prostatic carcinoma , 2016, Journal of magnetic resonance imaging : JMRI.
[2] Mehdi Moradi,et al. A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI , 2015, Comput. Medical Imaging Graph..
[3] J. Fütterer,et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.
[4] Oguz Akin,et al. Multimodality magnetic resonance imaging of prostate cancer. , 2010, Journal of endourology.
[5] T. Sone,et al. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. , 2011, AJR. American journal of roentgenology.
[6] W. See,et al. Thermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation , 2014, 2014 IEEE International Ultrasonics Symposium.
[7] R. Passariello,et al. Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer. , 2011, Urologic oncology.
[8] Geoffrey Watson,et al. Diffusion anisotropy in fresh and fixed prostate tissue ex vivo , 2016, Magnetic resonance in medicine.
[9] Jennifer J Kwak,et al. Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET , 2015, Current Oncology Reports.
[10] Abbas Samani,et al. A novel shape-similarity-based elastography technique for prostate cancer assessment. , 2015, Medical physics.
[11] Josep Comet,et al. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. , 2011, AJR. American journal of roentgenology.
[12] M. Collantes,et al. Index lesion characterization by 11C‐Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma , 2016, The Prostate.
[13] A. Oto,et al. IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model. , 2015, AJR. American journal of roentgenology.
[14] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.
[15] Y. Lotan,et al. The economic effect of using magnetic resonance imaging and magnetic resonance ultrasound fusion biopsy for prostate cancer diagnosis. , 2016, Urologic oncology.
[16] M. Roobol,et al. The value of an additional hypoechoic lesion‐directed biopsy core for detecting prostate cancer , 2008, BJU international.
[17] Ivan Pedrosa,et al. MR Imaging-Transrectal US Fusion for Targeted Prostate Biopsies: Implications for Diagnosis and Clinical Management. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.
[18] C. Morash,et al. Pictorial review. Magnetic resonance for radiotherapy management and treatment planning in prostatic carcinoma. , 2015, The British journal of radiology.
[19] N. Lawrentschuk,et al. Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy , 2015, Prostate international.
[20] C. Roehrborn,et al. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. , 2015, Urologic oncology.
[21] D. Nieboer,et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. , 2015, European urology.
[22] M. Vannier,et al. Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone? , 2015, Radiology.
[23] H. Hricak,et al. Molecular Imaging of Prostate Cancer. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.
[24] Werner Jaschke,et al. Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis , 2015, World Journal of Urology.
[25] Ian A. Donaldson,et al. Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis , 2014, BMJ Open.
[26] M. Blute,et al. Addressing the need for repeat prostate biopsy: new technology and approaches , 2015, Nature Reviews Urology.
[27] Rodolfo Montironi,et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. , 2007, European urology.
[28] J. Witjes,et al. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. , 2015, European urology.
[29] M. Roethke,et al. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard. , 2015, Journal of endourology.
[30] R. Piccazzo,et al. Multimodality fusion imaging in abdominal and pelvic malignancies: current applications and future perspectives , 2015, Abdominal Imaging.
[31] Jaime Gómez-Millán,et al. Advances in the treatment of prostate cancer with radiotherapy. , 2015, Critical reviews in oncology/hematology.
[32] N. Lumen,et al. What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? , 2016, European Radiology.
[33] Daniel J. A. Margolis,et al. Multiparametric MRI for Localized Prostate Cancer: Lesion Detection and Staging , 2014, BioMed research international.
[34] C. Kim,et al. Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration , 2016, European Radiology.
[35] C. Roehrborn,et al. Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer. , 2016, The Journal of urology.
[36] Yousef Mazaheri,et al. MRI of the prostate: Clinical relevance and emerging applications , 2011, Journal of magnetic resonance imaging : JMRI.
[37] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[38] Patrick Veit-Haibach,et al. Workflow in Simultaneous PET/MRI. , 2015, Seminars in nuclear medicine.
[39] C. Parker,et al. The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update , 2015, European Urology Focus.
[40] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[41] P Puech,et al. Detecting prostate cancer with MRI - why and how. , 2012, Diagnostic and interventional imaging.
[42] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[43] Rajan T. Gupta,et al. Current Trends and New Frontiers in Focal Therapy for Localized Prostate Cancer , 2015, Current Urology Reports.
[44] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[45] F. Schneider,et al. Impact of magnetic resonance imaging-guided prostate biopsy in the supine position on the detection of significant prostate cancer in an inhomogeneous patient cohort , 2016, Scandinavian journal of urology.
[46] D. Parente,et al. Multiparametric magnetic resonance imaging of the prostate. , 2013, Magnetic resonance imaging clinics of North America.
[47] P. Asbach,et al. MRT der Prostata , 2015, Der Radiologe.
[48] P. Choyke,et al. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy. , 2015, Urologic oncology.
[49] H. G. van der Poel,et al. Gross tumor volume and clinical target volume in prostate cancer: How do satellites relate to the index lesion. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[50] J. Trachtenberg,et al. In-bore MRI interventions: current status and future applications , 2015, Current opinion in urology.
[51] D. Dearnaley,et al. Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters , 2015, European Radiology.
[52] A. Ouzzane,et al. MRI in addition to or as a substitute for prostate biopsy: the clinician's point of view. , 2012, Diagnostic and interventional imaging.
[53] P. Brenner,et al. Tumor volume in insignificant prostate cancer: Increasing the threshold is a safe approach to reduce over‐treatment , 2015, The Prostate.
[54] Valeria Panebianco,et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.
[55] P. Mulders,et al. The value of magnetic resonance imaging and ultrasonography (MRI/US)‐fusion biopsy platforms in prostate cancer detection: a systematic review , 2016, BJU international.
[56] Thomas Hambrock,et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. , 2012, European urology.
[57] François Cornud,et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.
[58] Nicola Schieda,et al. False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance , 2015, Insights into Imaging.
[59] Yemisi Takwoingi,et al. MetaDAS: A SAS macro for meta-analysis of diagnostic accuracy studies , 2010 .
[60] Thomas Wiegel,et al. Guidelines on Prostate Cancer , 2013 .
[61] T. Fathelbab,et al. Value of functional MRI in evaluation of patients with suspected prostate cancer , 2015 .
[62] Karin Haustermans,et al. Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[63] V. Goh,et al. PET/MRI in Oncological Imaging: State of the Art , 2015, Diagnostics.
[64] T. Mitani,et al. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging? , 2011, Diagnostic and interventional radiology.
[65] Susan Mallett,et al. Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles , 2014, PloS one.
[66] Baris Turkbey,et al. Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer , 2016, CA: a cancer journal for clinicians.
[67] D. Moses,et al. Combination of multiparametric MRI and transperineal template‐guided mapping biopsy of the prostate to identify candidates for hemi‐ablative focal therapy , 2016, BJU international.
[68] Jiani Hu,et al. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. , 2012, AJR. American journal of roentgenology.
[69] C C Schulman,et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.
[70] Andrea Volpe,et al. Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives , 2011, Urologia Internationalis.
[71] M. Sumura,et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.